Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

v3.21.1
Subsequent Events
 3 Months Ended
Mar. 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
NOTE 7 – SUBSEQUENT EVENTS

A.

In April 2021, BiomX Israel received $992 (NIS 3,238) with respect to the December 2019 IIA approved program.

B. From April 1, 2021 through May 20, 2021, the Company issued an aggregate of 79,679 shares of Common Stock pursuant to the ATM Agreement for aggregate net proceeds of $503.

C.

In May 2021, BiomX Israel received $625 (NIS 2,042) with respect to the March 2021 IIA approved programs.